Are SGLT2 inhibitors safe for type 1 diabetes?
SGLT2 inhibitors have transformed care for people with type 2 diabetes. They not only lower blood sugar but also reduce cardiovascular events and slow the progression of kidney disease. Given these successes, many have asked whether the same benefits extend to people with type 1 diabetes (T1D).
The answer is not straightforward. In T1D, SGLT2 inhibitors remain off-label, and the biggest concern is the increased risk of diabetic ketoacidosis (DKA). Still, …











![How one physician redesigned her practice to find joy in primary care again [PODCAST]](https://kevinmd.com/wp-content/uploads/The-Podcast-by-KevinMD-WideScreen-3000-px-3-190x100.jpg)



![A neurosurgeon’s fight with the state medical board [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-1-190x100.jpg)
